We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Required Fields Sample Clauses

Required Fields. There are required fields on the eCVI. They must remain required and be completed in order for the certificate to be issued and official.
Required Fields. In the Enterprise Permitting & Licensing software, some fields are “Required Fields,” and the associated columns must be populated for records to be written to the Enterprise Permitting & Licensing db. On occasion, these required fields will not be available in the legacy source data, so a simple default value can be written to the EG_Template db to fulfill any NOT NULL constraint. Dropdown picklist columns restrict the user from entering certain values in the Enterprise Permitting & Licensing db. Conversely, drop-down fields do not have a restriction on values written to the EG_Template db. Therefore, exact spelling or careful matching to the Enterprise Permitting & Licensing configured values is not a requirement for fields intended for Enterprise Permitting & Licensing drop-down fields. Tyler maps the values through a separate table to translate the values to the appropriate Enterprise Permitting & Licensing value during conversion and collaborates with the Jackson County to validate the resulting mappings during the development phase of the conversion. Custom Fields (any fields not available in the master table for the module in question) Most legacy systems have some attribute fields that are not specified in the corresponding master table within EG_Template. Xxxxx refers to these as custom fields. Within each module exists a child table for such custom fields. Since these fields are specific to the legacy system(s), the Jackson County may add columns to these tables in EG_Template to accommodate any needed custom fields in the migration. For example, ‘permit_additional_fields’ is the table for extra fields relating to the ‘permit’ records. Gap Handling (where legacy data doesn’t fit anywhere within EG_Template) On occasion, legacy systems contain special features for which Enterprise Permitting & Licensing does not account in the EG_Template db. As a result, the need may arise to develop a modified solution to address special cases. Contacts Contacts generally fall into two categories:
Required Fields. All required fields on the MI eCVI must be completed for the certificate to be issued and considered official.
Required Fields. Fields in red are required on the eCVI and must be completed in order for the certificate to be issued and official.
Required Fields. The followingfields are required on the certificate, and are used to maintain uniformity in data collection, integration into data management systems and meet USDAstandards: a. Inspection Date b. Consignor Info: first and last name, physicaladdress, city, state, zip, county and phone number c. Consignee Info: first and last name, physical address, city, state and zip d. Purpose of Movement e. Species/Species Number x. x ] v ] v [ ^ ] P v g. Date of Signature h. Veterinari an Printed Name i. Veterinarian Contact Information: Address, Phone Number, Email j. Veterinarian Federal Accreditation Number
Required Fields. There are required fields on the MN eCVI. They must remain required and be completed in order for the certificate to be issued and official. These required fields are highlighted in red on the form. States of destination may consider other fields to be required based on their import requirements. Note: Consignor/Origin Info and Consignee/Destination Info must include physical addresses of where the animals originated and are destined.
Required Fields. Fields marked with an * are required on the eCVI to maintain uniformity in data collection, integration into data management systems and to meet USDA standards except State of License and License Number. These blocks are marked N/A. The required fields are: a. Inspection Date b. Consignor Info: First and Last Name, Physical Address, City, State, Zip, County and Phone Number c. Consignee Info: First and Last Name, Physical Address, City, State, and Zip d. Purpose of Movement e. Species/Species Number f. Veterinarian’s Signature g. Date of Signature h. Veterinarian Printed Name i. Veterinarian Contact Information: Address, Phone Number, Email j. Veterinarian Federal Accreditation Number
Required Fields. Inform Medix Clients of those fields that must be completed in order to process the Lab Order. If such fields are not completed, Lab Order shall be rejected and a warning notice sent to Medix Client by Medix System.

Related to Required Fields

  • Competing Products The provisions of Section 21 are set forth on attached Exhibit H and are incorporated in this Section 21 by this reference.

  • Territory 33.1 This Agreement applies to the territory in which CenturyLink operates as an ILEC in the State. CenturyLink shall be obligated to provide services under this Agreement only within this territory. 33.2 Notwithstanding any other provision of this Agreement, CenturyLink may terminate this Agreement as to a specific operating territory or portion thereof pursuant to Section 6.7 of this Agreement.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Competitive Products Competitive Products" means products that serve the same function as, or that could be used to replace, products the Company provided to, offered to, or was in the process of developing for a present, former, or future possible customer/partner at any time during the twelve (12) months immediately preceding the last day of Participant's employment (or at any time during Participant's employment if Participant was employed for less than 12 months), with which Participant had direct responsibility for the sale or development of such products or managing those persons responsible for the sale or development of such products.

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Territorial application This Agreement shall apply, on the one hand, to the territories in which the Treaty establishing the European Community is applied, and under the conditions laid down in that Treaty and, on the other hand, to the territory of the United States.

  • Manufacturing and Marketing Rights The Company has not granted rights to manufacture, produce, assemble, license, market, or sell its products to any other person and is not bound by any agreement that affects the Company's exclusive right to develop, manufacture, assemble, distribute, market, or sell its products.

  • Licensed Product The term “Licensed Product” shall mean any product (a) the manufacture, use, importation, sale or offer for sale of which would, in the absence of the license granted by this Agreement, infringe a Valid Claim of any of the Licensed Patent Rights, or (b) that is comprised of, utilizes or incorporates Licensed Biological Materials, or (c) that is discovered, developed or made using a Licensed Process.

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.